(Q35640621)

English

Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer

scientific article published on December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Leonard G Gomella

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ilia Zeltser

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Richard K Valicenti

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

62 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

46-54

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Radiation therapy after radical prostatectomy: A review of the issues and options

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

The metabolism of testosterone and dihydrotestosterone in an androgen-dependent tumour. A possible correlation between dihydrotestosterone and tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Apoptosis, tumour invasion and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Tr

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Hormonal treatment before radical prostatectomy: a 3-year followup

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

A review of studies of hormonal adjuvant therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Radiation therapy after prostatectomy: now or later?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Adjuvant radiotherapy in patients post radical prostatectomy with tumor extending through capsule or positive seminal vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Adjuvant mitozantrone chemotherapy in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

Nomograms as predictive models

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLOGY.2003.10.025

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35640621&oldid=2049305408"